Deutsche Bank’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-132,597
| Closed | -$137K | – | 5202 |
|
|
2019
Q1 | $137K | Buy |
132,597
+77,897
| +142% | +$80.5K | ﹤0.01% | 4069 |
|
|
2018
Q4 | $40K | Buy |
+54,700
| New | +$40K | ﹤0.01% | 4306 |
|
|
2018
Q2 | – | Sell |
-54
| Closed | – | – | 5202 |
|
|
2018
Q1 | $0 | Sell |
54
-2,930
| -98% | – | ﹤0.01% | 5221 |
|
|
2017
Q4 | $12K | Buy |
2,984
+1,568
| +111% | +$6.31K | ﹤0.01% | 4295 |
|
|
2017
Q3 | $5K | Sell |
1,416
-17,980
| -93% | -$63.5K | ﹤0.01% | 4269 |
|
|
2017
Q2 | $63K | Sell |
19,396
-98,489
| -84% | -$320K | ﹤0.01% | 4082 |
|
|
2017
Q1 | $1.08M | Sell |
117,885
-9,224
| -7% | -$84.8K | ﹤0.01% | 2566 |
|
|
2016
Q4 | $979K | Buy |
127,109
+36,075
| +40% | +$278K | ﹤0.01% | 2671 |
|
|
2016
Q3 | $1.04M | Buy |
91,034
+46,674
| +105% | +$533K | ﹤0.01% | 2764 |
|
|
2016
Q2 | $544K | Buy |
44,360
+4,116
| +10% | +$50.5K | ﹤0.01% | 3177 |
|
|
2016
Q1 | $406K | Buy |
40,244
+10,089
| +33% | +$102K | ﹤0.01% | 3269 |
|
|
2015
Q4 | $678K | Sell |
30,155
-28,320
| -48% | -$637K | ﹤0.01% | 3056 |
|
|
2015
Q3 | $969K | Buy |
58,475
+6,233
| +12% | +$103K | ﹤0.01% | 2926 |
|
|
2015
Q2 | $1.17M | Buy |
52,242
+9,486
| +22% | +$213K | ﹤0.01% | 2820 |
|
|
2015
Q1 | $1.1M | Sell |
42,756
-55,195
| -56% | -$1.42M | ﹤0.01% | 2791 |
|
|
2014
Q4 | $2.13M | Sell |
97,951
-2,938
| -3% | -$63.8K | ﹤0.01% | 2597 |
|
|
2014
Q3 | $1.91M | Buy |
100,889
+19,776
| +24% | +$374K | ﹤0.01% | 2526 |
|
|
2014
Q2 | $1.89M | Buy |
81,113
+13,340
| +20% | +$311K | ﹤0.01% | 2452 |
|
|
2014
Q1 | $2.28M | Sell |
67,773
-49,566
| -42% | -$1.67M | ﹤0.01% | 2328 |
|
|
2013
Q4 | $3.46M | Buy |
117,339
+700
| +0.6% | +$20.7K | ﹤0.01% | 1979 |
|
|
2013
Q3 | $1.79M | Buy |
+116,639
| New | +$1.79M | ﹤0.01% | 2560 |
|